Key points from article :
Will produce cells derived from iPS cells for commercial applications.
Existing iPSC production facilities have only made cells available to researchers.
Will use induced pluripotent stem cells produced at Kyoto University.
Three zones will produce different types of cells to treat hundreds of patients per year.
Construction of the center cost approximately 3.6 billion yen ($342.7 million USD)
